InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Stephan Dietrich A, Chairman & CEO. Insider active across 1 companies, notably NeuBase Therapeutics, Inc.. Aggregated, 2 filings have been published. The latest transaction was filed on 31 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€3742,250 shares@ €0.0009100.0% of flow
Common Stock
SEC:0001104659-22-001691·
€3742,250 shares@ €0.000950.0% of flow
Common Stock
SEC:0001104659-22-001691:0·
2 of 2 declarations
About Stephan Dietrich A
Stephan Dietrich A is the President and CEO of NeuBase Therapeutics, Inc. In this role, he is responsible for the strategic direction of the company and the management of its operations. His leadership is essential to achieve the growth and innovation objectives of NeuBase Therapeutics, Inc.
